Ledger.Open graph →
SEC Form D · filed October 28, 2021

InMed Pharmaceuticals Inc

Offering
$4.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Catherine A. Sazdanoff · Vancouver, British Columbia, CanadaDirectorAlexandra D. Mancini · Vancouver, British Columbia, CanadaExecBruce S. Colwill · Vancouver, British Columbia, CanadaExecEric C. Hsu · Vancouver, British Columbia, CanadaExecAndrew J. Hull · Vancouver, British Columbia, CanadaDirectorEric A. Adams · Vancouver, British Columbia, CanadaExec · DirectorMichael C. Woudenberg · Vancouver, British Columbia, CanadaExecAdam A. Cutler · Vancouver, British Columbia, CanadaDirectorWilliam J. Garner · Vancouver, British Columbia, CanadaDirectorYuridia V. Rodriguez · Grand Rapids, MIDirectorJeff S. Drummond · Bellevue, WAExecKenneth S. Cornick · Bellevue, WADirectorPamela J. Brewster · Hamilton, MTExecCraig M. Hurlbert · Hamilton, MTExecRommel V. Vega · Grand Rapids, MIDirectorNaveen Singh · Bellevue, WADirectorS. S. Singh · Bellevue, WAExec · DirectorUtpal S. Donde · Bellevue, WAExecRobert Azeke · New York, NYDirectorCharles King · Murfreesboro, TNDirectornull Dreavent Inc · Cambridge, MADirectorCharles Farguson · New York, NYExecRyan W. Howe · Cedar Falls, IAExec · DirectorAngela W. Strange · Cedar Falls, IADirectorRobert W. Smith, Jr · Cedar Falls, IAExecSimon W. Barne · Boston, MAExecYosef A. Quint · Westwood, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗